New drug cocktail aims to crush resistant leukemia
Disease control
Recruiting now
This phase 2 trial tests whether combining pirtobrutinib and venetoclax can eliminate signs of cancer in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has stopped responding to standard BTK inhibitors. About 30 adults currently taking i…
Phase: PHASE2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC